FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2124135969> ?p ?o ?g. }

• W2124135969 endingPage "452" @default.
• W2124135969 startingPage "444" @default.
• W2124135969 abstract "Background: Patients with breast cancer often receive emetogenic anthracycline–based chemotherapy as part of their treatment. Chemotherapy-induced nausea and vomiting (CINV) has been commonly reported as one of the distressing adverse effects among patients with cancer. Despite the advent of newer antiemetics and better understanding of the CINV pathophysiology, total eradication of CINV has yet to be achieved. Objective: To assess the incidence of nausea and vomiting in patients who have breast cancer and are receiving adjuvant doxorubicin and cyclophosphamide (AC) bolus chemotherapy, ascertain patients’ risk factors affecting CINV response, and study patient adherence to delayed antiemetics. Methods: This was a single-institution, prospective, observational study conducted at an outpatient cancer center in Singapore from December 2006 to December 2007. Clinical events such as CINV were collated using a standardized diary. Use of rescue antiemetics and unscheduled clinic visits due to CINV were documented. Results: Of a total of 108 participants, 16 patients were lost to follow-up and 1 provided incomplete information; thus, 91 patients were included in the analysis. Delayed antiemetics were given according to the institution's guideline and only 9 (9.9%) patients received aprepitant. Neither acute nor delayed vomiting was reported by a majority of patients and only 4 (4.4%) experienced grade 3 vomiting. The incidence of severe nausea was highest on day 3 of chemotherapy and affected 14.3% of patients. Anxiety and history of chemotherapy-induced nausea were associated with both acute and delayed nausea, and history of motion sickness was associated with delayed vomiting. Approximately 65% of patients were adherent to their prescribed delayed antiemetics. Conclusions: Most of our patients adhered to their antiemetics and tolerated AC chemotherapy reasonably well, without vomiting; yet nausea persisted. To improve CINV control, clinicians must actively communicate with patients to facilitate accurate assessment of risk factors and CINV response and to encourage adherence to delayed antiemetics." @default.
• W2124135969 created "2016-06-24" @default.
• W2124135969 creator A5033584533 @default.
• W2124135969 creator A5060981830 @default.
• W2124135969 creator A5089890846 @default.
• W2124135969 date "2009-03-01" @default.
• W2124135969 modified "2023-09-27" @default.
• W2124135969 title "Clinical Predictors of Chemotherapy-Induced Nausea and Vomiting in Breast Cancer Patients Receiving Adjuvant Doxorubicin and Cyclophosphamide" @default.
• W2124135969 cites W1262485082 @default.
• W2124135969 cites W191903215 @default.
• W2124135969 cites W1970295647 @default.
• W2124135969 cites W1979543535 @default.
• W2124135969 cites W1982828937 @default.
• W2124135969 cites W1994979504 @default.
• W2124135969 cites W2003911198 @default.
• W2124135969 cites W2012005071 @default.
• W2124135969 cites W2022678064 @default.
• W2124135969 cites W2023111165 @default.
• W2124135969 cites W2023279674 @default.
• W2124135969 cites W2039700056 @default.
• W2124135969 cites W2041576066 @default.
• W2124135969 cites W2046417971 @default.
• W2124135969 cites W2050861645 @default.
• W2124135969 cites W2052698280 @default.
• W2124135969 cites W2073501285 @default.
• W2124135969 cites W2074318951 @default.
• W2124135969 cites W2085693190 @default.
• W2124135969 cites W2085759818 @default.
• W2124135969 cites W2098265241 @default.
• W2124135969 cites W2102908828 @default.
• W2124135969 cites W2107985230 @default.
• W2124135969 cites W2113622674 @default.
• W2124135969 cites W2131206836 @default.
• W2124135969 cites W2136818862 @default.
• W2124135969 cites W2138543169 @default.
• W2124135969 cites W2148594906 @default.
• W2124135969 cites W2158036326 @default.
• W2124135969 cites W2288052218 @default.
• W2124135969 cites W2326068394 @default.
• W2124135969 cites W2493148753 @default.
• W2124135969 cites W252362330 @default.
• W2124135969 cites W47442776 @default.
• W2124135969 doi "https://doi.org/10.1345/aph.1l437" @default.
• W2124135969 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19193584" @default.
• W2124135969 hasPublicationYear "2009" @default.
• W2124135969 type Work @default.
• W2124135969 sameAs 2124135969 @default.
• W2124135969 citedByCount "58" @default.
• W2124135969 countsByYear W21241359692012 @default.
• W2124135969 countsByYear W21241359692013 @default.
• W2124135969 countsByYear W21241359692014 @default.
• W2124135969 countsByYear W21241359692015 @default.
• W2124135969 countsByYear W21241359692016 @default.
• W2124135969 countsByYear W21241359692017 @default.
• W2124135969 countsByYear W21241359692018 @default.
• W2124135969 countsByYear W21241359692019 @default.
• W2124135969 countsByYear W21241359692020 @default.
• W2124135969 countsByYear W21241359692021 @default.
• W2124135969 countsByYear W21241359692022 @default.
• W2124135969 crossrefType "journal-article" @default.
• W2124135969 hasAuthorship W2124135969A5033584533 @default.
• W2124135969 hasAuthorship W2124135969A5060981830 @default.
• W2124135969 hasAuthorship W2124135969A5089890846 @default.
• W2124135969 hasConcept C121608353 @default.
• W2124135969 hasConcept C126322002 @default.
• W2124135969 hasConcept C2776694085 @default.
• W2124135969 hasConcept C2776755627 @default.
• W2124135969 hasConcept C2776802502 @default.
• W2124135969 hasConcept C2779924295 @default.
• W2124135969 hasConcept C2780574406 @default.
• W2124135969 hasConcept C2780580376 @default.
• W2124135969 hasConcept C2780852908 @default.
• W2124135969 hasConcept C2780884295 @default.
• W2124135969 hasConcept C42219234 @default.
• W2124135969 hasConcept C530470458 @default.
• W2124135969 hasConcept C71924100 @default.
• W2124135969 hasConceptScore W2124135969C121608353 @default.
• W2124135969 hasConceptScore W2124135969C126322002 @default.
• W2124135969 hasConceptScore W2124135969C2776694085 @default.
• W2124135969 hasConceptScore W2124135969C2776755627 @default.
• W2124135969 hasConceptScore W2124135969C2776802502 @default.
• W2124135969 hasConceptScore W2124135969C2779924295 @default.
• W2124135969 hasConceptScore W2124135969C2780574406 @default.
• W2124135969 hasConceptScore W2124135969C2780580376 @default.
• W2124135969 hasConceptScore W2124135969C2780852908 @default.
• W2124135969 hasConceptScore W2124135969C2780884295 @default.
• W2124135969 hasConceptScore W2124135969C42219234 @default.
• W2124135969 hasConceptScore W2124135969C530470458 @default.
• W2124135969 hasConceptScore W2124135969C71924100 @default.
• W2124135969 hasIssue "3" @default.
• W2124135969 hasLocation W21241359691 @default.
• W2124135969 hasLocation W21241359692 @default.
• W2124135969 hasOpenAccess W2124135969 @default.
• W2124135969 hasPrimaryLocation W21241359691 @default.
• W2124135969 hasRelatedWork W1480067006 @default.
• W2124135969 hasRelatedWork W1747184343 @default.
• W2124135969 hasRelatedWork W2037755310 @default.
• W2124135969 hasRelatedWork W2057039455 @default.

• next